Big Pharma’s Hot Streak — and What Could Stop It
The pharmaceutical industry is on a bit of a hot streak. Last Monday, Pfizer announced promising results for its coronavirus vaccine. Later that day, Eli Lilly received emergency-use authorization from the FDA for its antibody treatment, which may prevent COVID-19 from growing serious in patients who contract the coronavirus and are not yet hospitalized. Not to be outdone, Moderna released similarly positive results for its vaccine candidate yesterday.